Posttransplant lymphoproliferative disorder in liver allograft biopsies: A comparison of three methods for the demonstration of Epstein-Barr virus

被引:25
|
作者
Lones, MA
Shintaku, IP
Weiss, LM
Thung, SN
Nichols, WS
Geller, SA
机构
[1] CEDARS SINAI MED CTR,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90048
[2] ST JOSEPH HOSP,CHILDRENS HOSP,DEPT PATHOL,ORANGE,CA
[3] CITY HOPE NATL MED CTR,DEPT PATHOL,DUARTE,CA 91010
[4] MT SINAI SCH MED,DEPT PATHOL,NEW YORK,NY
关键词
posttransplant lymphoproliferative disorder; liver allograft; Epstein-Barr virus; EBER; latent membrane protein;
D O I
10.1016/S0046-8177(97)90074-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Posttransplant lymphoproliferative disorder (PTLD) is associated with Epstein-Barr virus (EBV), and may clinically resemble acute allograft rejection. Three methods to show EBV in tissue were evaluated in 15 liver allograft biopsies from 12 patients including four with PTLD: (1) semiquantitative polymerase chain reaction (PCR) for EBV DNA; (2) in situ hybridization for EBV RNA (EBER); and (3) immunoperoxidase for EBV latent membrane protein (LMP). Index cases had a PCR dot blot result of ''positive'' or ''weak positive.'' Findings were correlated with histology, clinical data, therapy, and outcome. All four PTLD patients had a clinical diagnosis of acute rejection. All four showed EBV: PCR 4, LEER 4, LMP 3. Liver function tests were elevated in three, but EBV viral capsid antigen (VCA) IgM was not increased in three. Immunosuppression was withdrawn and all four patients underwent a second transplantation. One died 4 days posttransplant with disseminated PTLD, two died of sepsis at 1.5 and 14 months, and one is well at 3 years without PTLD. Eleven biopsies without PTLD showed: acute rejection 7, acute rejection and hepatitis 1, hepatitis B 1, and non-inflammatory changes 2. In this group, EBV results included: PCR weak positive in 10 and 1+ in one, EBER negative in ten and rare positive cells in one, LMP negative in 11. Liver function tests were elevated in 10, whereas VCA IgM was not increased in three and increased in one. Patients with acute rejection were treated with increased immunosuppression: none developed PTLD, with follow-up of at least 6 months in nine cases. Two patients died within 4 months of biopsy. One patient with PTLD in tonsils had a liver biopsy showing both acute rejection and EBV (PCR 1+, rare EBER + small cells). Histological studies combined with special EBV detection methods, can be useful to evaluate atypical lymphoid infiltrates in liver allograft biopsies and confirmation of a diagnosis of PTLD. All three methods are useful; EBER and PCR are the most sensitive. LEER and LMP fan use paraffin sections. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 50 条
  • [1] Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
    Green, M.
    Michaels, M. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 41 - 54
  • [2] Allograft liver biopsy in patients with Epstein-Barr virus - Associated posttransplant lymphoproliferative disease
    Randhawa, P
    Blakolmer, K
    Kashyap, R
    Raikow, R
    Nalesnik, M
    Demetris, AJ
    Jain, A
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (03) : 324 - 330
  • [3] Epstein-Barr virus and posttransplant lymphoproliferative disease
    Holmes, R
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 (04): : 442 - 444
  • [4] Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes
    Lindsay, Julian
    Othman, Jad
    Heldman, Madeleine R.
    Slavin, Monica A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (06) : 635 - 645
  • [5] Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation
    Allen, U. D.
    Preiksaitis, J. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 107 - 120
  • [6] Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients
    Allen, U.
    Preiksaitis, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S87 - S96
  • [7] ANTIVIRAL PROPHYLAXIS AND THE EPSTEIN-BARR VIRUS-RELATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER
    DAVIS, CL
    HARRISON, KL
    MCVICAR, JP
    FORG, P
    BRONNER, M
    MARSH, CL
    CLINICAL TRANSPLANTATION, 1995, 9 (01) : 53 - 59
  • [8] Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder
    Capaldi, L
    Robinson-Bostom, L
    Kerr, P
    Gohh, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 778 - 780
  • [9] HEART ALLOGRAFT INVOLVEMENT WITH EPSTEIN-BARR-VIRUS ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER
    ABUFARSAKH, H
    CAGLE, PT
    BUFFONE, GJ
    BRUNER, JM
    WEILBAECHER, D
    GREENBERG, SD
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (01) : 93 - 95
  • [10] Epstein-Barr virus-induced, posttransplant lymphoproliferative disorders
    Paya, CV
    Fung, JJ
    Nalesnik, MA
    Kieff, E
    Green, M
    Gores, G
    Habermann, TM
    Wiesner, RH
    Swinnen, LJ
    Woodle, ES
    Bromberg, JS
    TRANSPLANTATION, 1999, 68 (10) : 1517 - 1525